Income Taxes	9 Months Ended
Mar. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Note 13. Income Taxes The Company recorded an income tax expense of $5.6 million and $22.2 million for the three and nine months ended March 30, 2019, respectively. The Company recorded income tax expense of $3.1 million and $4.3 million for the three and nine months ended March 31, 2018, respectively. The income tax expense for the three and nine months ended March 30, 2019 and March 31, 2018 primarily relates to income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss for the respective fiscal year. For the three and nine months ended March 31, 2018, this foreign and state tax is offset by a tax benefit of $2.0 million and $5.1 million, respectively, which was recorded in the Company’s income tax provision related to the income tax intraperiod allocation rules in relation to other comprehensive income. On December 22, 2017, the U.S. Tax Cuts and Jobs Act was enacted. The Act imposed a deemed repatriation of the Company’s foreign subsidiaries’ post-1986 earnings and profits (“E&P”) which had previously been deferred from US income tax. This deemed repatriation was reported in the Company’s fiscal 2018 U.S. tax return. The Company completed the calculation of the total post-1986 foreign E&P for all foreign subsidiaries during the quarter ended December 29, 2018. The change in estimate did not materially impact the Company’s financial statements. The income tax expense recorded differs from the expected tax benefit that would be calculated by applying the federal statutory rate to the Company’s loss from continuing operations before taxes primarily due to the changes in valuation allowance for deferred tax assets attributable to the Company’s domestic and foreign income (loss) from continuing operations, and due to the income tax benefit recorded in continuing operations under the income tax intraperiod allocation rules. As of March 30, 2019, and June 30, 2018, the Company’s unrecognized tax benefits totaled $53.3 million and $48.6 million, respectively, and are included in deferred taxes and other non-current tax liabilities, net. The Company had $2.0 million accrued for the payment of interest and penalties at March 30, 2019. The unrecognized tax benefits that may be recognized during the next twelve months are approximately $0.8 million.

Note 13. Income Taxes

The Company recorded an income tax expense of $5.6 million and $22.2 million for the three and nine months ended March 30, 2019, respectively. The Company recorded income tax expense of $3.1 million and $4.3 million for the three and nine months ended March 31, 2018, respectively.

The income tax expense for the three and nine months ended March 30, 2019 and March 31, 2018 primarily relates to income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss for the respective fiscal year. For the three and nine months ended March 31, 2018, this foreign and state tax is offset by a tax benefit of $2.0 million and $5.1 million, respectively, which was recorded in the Company’s income tax provision related to the income tax intraperiod allocation rules in relation to other comprehensive income.

On December 22, 2017, the U.S. Tax Cuts and Jobs Act was enacted. The Act imposed a deemed repatriation of the Company’s foreign subsidiaries’ post-1986 earnings and profits (“E&P”) which had previously been deferred from US income tax. This deemed repatriation was reported in the Company’s fiscal 2018 U.S. tax return. The Company completed the calculation of the total post-1986 foreign E&P for all foreign subsidiaries during the quarter ended December 29, 2018. The change in estimate did not materially impact the Company’s financial statements.

The income tax expense recorded differs from the expected tax benefit that would be calculated by applying the federal statutory rate to the Company’s loss from continuing operations before taxes primarily due to the changes in valuation allowance for deferred tax assets attributable to the Company’s domestic and foreign income (loss) from continuing operations, and due to the income tax benefit recorded in continuing operations under the income tax intraperiod allocation rules.

As of March 30, 2019, and June 30, 2018, the Company’s unrecognized tax benefits totaled $53.3 million and $48.6 million, respectively, and are included in deferred taxes and other non-current tax liabilities, net. The Company had $2.0 million accrued for the payment of interest and penalties at March 30, 2019. The unrecognized tax benefits that may be recognized during the next twelve months are approximately $0.8 million.